ID: ALA111802

Max Phase: Preclinical

Molecular Formula: C14H8F3NO2

Molecular Weight: 279.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(N1c2ccccc2Oc2ccccc21)C(F)(F)F

Standard InChI:  InChI=1S/C14H8F3NO2/c15-14(16,17)13(19)18-9-5-1-3-7-11(9)20-12-8-4-2-6-10(12)18/h1-8H

Standard InChI Key:  VXQXLIQHPNDAOI-UHFFFAOYSA-N

Associated Targets(Human)

KB 17409 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

GC3/Cl 69 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 279.22Molecular Weight (Monoisotopic): 279.0507AlogP: 4.02#Rotatable Bonds: 0
Polar Surface Area: 29.54Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.39CX LogD: 3.39
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.73Np Likeness Score: -0.58

References

1. Thimmaiah KN, Horton JK, Seshadri R, Israel M, Houghton JA, Harwood FC, Houghton PJ..  (1992)  Synthesis and chemical characterization of N-substituted phenoxazines directed toward reversing vinca alkaloid resistance in multidrug-resistant cancer cells.,  35  (18): [PMID:1527786] [10.1021/jm00096a009]

Source